Saúde
Does Ozempic slow aging? Here is what the SELECT, STEP, and EVOKE trials actually measured, and what they don't yet show.
An Anvisa GLP-1 registration check confirms a pen's status in Brazil, but it can't confirm your prescription, your dose, or whether the box in your hand is genuine. Here's how to read the results and where to be careful.
Ozempic pregnancy planning starts with the clock. Here is how semaglutide's long washout, contraception, and mid-treatment surprises fit together.
Your liver handles sugar, fat, and medications, so it matters during GLP-1 treatment. Here is what fatty liver is, what the studies show, and what to ask your doctor.
Brazilian customs and health authorities have intensified seizures of irregular weight loss medications at major entry points. Here's what consumers need to know about the findings and the risks involved.
Research is uncovering a surprising connection between your gut bacteria and how well GLP-1 medications like semaglutide work for weight loss. Here's what the science says.
The parallel market for GLP-1 pens offers accessible prices but carries serious risks. OzemNews explains what patients need to understand before sourcing medications outside authorized channels.
Researchers are exploring how GLP-1 medications interact with gut bacteria. Here's what we know so far about this emerging area of study.
A science-backed look at how opioid receptors and endogenous opioids shape brain chemistry, and what emerging research reveals about GLP-1 agonists' unexpected interaction with this system.
The conversation around GLP-1 medications has shifted dramatically. Beyond impressive weight loss results, a growing body of cardiovascular outcome trials suggests these drugs may protect the heart in ways that go far beyond the number on the scale.
